4-Dimethylaminobenzoic acid Cas:619-84-1

We are 4-Dimethylaminobenzoic acid CAS:619-84-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

4-Dimethylaminobenzoic acid

4-Dimethylaminobenzoic acid
4-(dimethylamino)benzoic acid
Benzoic acid, 4-(dimethylamino)-

molecular formula: C9H11NO2
Molecular weight: 165.18900
Physical Properties:
Appearance and properties: white to light yellow crystalline powder
Density: 1.18 g/cm3
Boiling point: 315.8ºC at 760 mmHg
Melting point: 241-243 °C (dec.)(lit.)
Flash point: 170 °C
Refractive index: 1,3715

Appearance:White to pale yellow crystalline powder
PURITY  :99.0%min

It is used as an important intermediate of photosensitizer, paint and dye intermediate. Intermediates of fine chemicals, synthesis of high-efficiency photosensitive materials, used in photoelectric conversion devices, and can be used in coatings and ultraviolet radiation.
Package and Storage:
1kg/bottle or bag
25kgs/drum or bag

Market News:SARS-CoV-2 has evolved mutations that severely compromise the neutralizing activities of multiple IgG monoclonal antibodies, including those under clinical trials and authorized for emergency use.
Therefore, developing new antibody therapies that can overcome these challenges is an urgent unmet need, and we are pleased with the data published today,” An said.
“Synergizing the strengths of multiple institutions from academia and industry is the key to the rapid translation from ideas to therapeutic candidates.
This is another example of such success. The cross-institutional and academic-industry collaborations should be expanded to other disease indications,” said Pei-Yong Shi, PhD, professor and co-senior author of the study from the Department of Biochemistry and Molecular Biology at UTMB Health.
This antibody has been licensed to biotech partner IGM Biosciences for drug development.
“The ability to use potently neutralizing IgM antibodies against SARS-CoV-2 with broad coverage of VOCs, VOIs, and viral escape mutants, is a very exciting application of the IGM platform,” said Fred Schwarzer, CEO of IGM Biosciences.
“We are grateful to our collaborators at UTHealth, UTMB Health, and our scientists at IGM for the exceptional work described in Nature today. 4-N-ethylsulfonylamino-2,2,6,7-tetramethylchroman manufacturer.High viral load in the respiratory tract correlates with severe illness and mortality in patients with COVID-19,” said Zhiqiang An, PhD, director of UTHealth Texas Therapeutics Institute, professor and Robert A. Welch Distinguished University Chair in Chemistry at McGovern Medical School at UTHealth, and faculty member at MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences and one of the corresponding authors on the study.
“Respiratory mucosal antibodies are key to clearing SARS-CoV-2 infection and reducing viral transmission and IgM antibodies are nature’s first line of defense against pathogens such as viruses. 4-methyl-3-styryl-pyridine supplier.Here’s how Biogen did during the three months ended June 30 compared with what Wall Street expected, according to average estimates compiled by Refinitiv. 1-(1,1-dimethylethyl)-3-(2-phenylethynyl)benzene producer.

Related Products
Product Name
2-Amino-6-fluorobenzoic acid View Details
3-Methyl-4-methylthiophenol View Details
2-Nitroaminoimidazoline View Details
(1R-cis)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane carboxylic acid manufacturer 2,4-Dichlorophenol manufacturer Triethylammonium chloride Cas:554-68-7 manufacturer 4-Bromo-2-fluoropyridine manufacturer 6-(chloromethyl)-11H-benzo[c][1]benzazepine manufacturer